Defined as substances that inhibit microbial growth
Essential in treating infections caused by bacteria and other microorganisms.
Assess the need for antimicrobial agents.
Describe therapeutic indications for their use.
Prioritize the prescribing of appropriate agents based on clinical scenarios.
Systemic Approach: Thorough assessment to identify the source of infection.
Setting of Infection: Consider the location and context of the infection.
Conduct a Physical Exam.
Evaluate Chief Complaint and Present Illness.
Note any Recent Travel and Past History.
Identify the Source of the infection.
Perform necessary Lab Tests.
Recognize when body and immune defenses have failed leading to a 'sick' patient.
Direct Microscopic Visualization
Culture and Identification: Culturing the pathogen to determine the infectious organism.
Detection of Microbial Antigens: Identifying specific microbial markers in the body.
Detection of Microbial RNA or DNA: Utilizing molecular methods for pathogen identification.
Host Immune Response Detection: Understanding how the host's immune system is responding to the pathogen.
Gram-Negative Bacteria:
Characterized by an outer membrane containing lipopolysaccharides.
Gram-Positive Bacteria:
Composed of thick peptidoglycan layers without an outer membrane.
Broad Spectrum: Effective against a wide range of bacteria.
Narrow Spectrum: Target specific types of bacteria.
Bactericidal: Kill bacteria.
Bacteriostatic: Inhibit bacterial growth without killing them.
Common tests include Kirby-Bauer Antibiotic Sensitivity Test and Minimum Inhibitory/Bactericidal Concentration Tests.
Inhibition of Cell Wall Synthesis: Prevents bacteria from forming cell walls.
Inhibition of Nucleic Acid Synthesis: Interferes with the replication or transcription of bacterial DNA.
Disruption of Cell Membrane Integrity: Alters the membrane structure, leading to cell death.
Inhibition of Protein Synthesis: Disrupts translating processes, affecting bacterial growth.
Inhibition of Metabolic Pathways: Block necessary biochemical pathways for bacterial survival.
Causes: Bacterial production of enzymes (e.g., penicillinase) that neutralize antibiotics.
Mechanisms: Includes the destruction of the antibiotic (e.g., breaking the beta-lactam ring) or inhibiting its action.
β-lactam/β-lactamase Inhibitors: Agents like clavulanic acid enhance antibiotic efficacy against resistant strains.
Classified by Spectrum of Activity: Natural, resistant, aminopenicillins, and extended spectrum.
Mechanism of Action: Inhibit bacterial cell wall synthesis.
Common Uses: Effective against various infections including respiratory and soft tissue infections.
Adverse Events: Mostly hypersensitivity reactions; can cause seizures in cases of severe renal dysfunction.
Pharmacokinetics: Well absorbed; good penetration into tissues; primarily renal excretion.
Cross-sensitivity with Penicillins: Possible (3%-10%) if patients have significant allergies to penicillin.
Uses: Versatile use in treating various infections with a favorable toxicity profile.
Mechanism of Action: Concentration-dependent killing effect.
Absorption and Distribution: Good tissue penetration with renal elimination.
Adverse Effects: Risk of tendon rupture, QTc prolongation, and neuropathy.
Examples: Erythromycin, Azithromycin, Clarithromycin.
Uses: Commonly prescribed for respiratory tract infections and STDs; good tissue penetration.
Adverse Effects: GI distress, potential drug interactions with CYP450 inhibitors.
Broad Spectrum Activity: Effective against a variety of bacteria including gram-positive, gram-negative, and atypical organisms.
Adverse Effects: Photosensitivity, potential effects on bone and tooth development in children (discoloration).
Administration: Primarily parenteral due to poor GI absorption.
Uses: Effective against systemic infections, particularly gram-negative bacteria.
Adverse Effects: Nephrotoxicity and ototoxicity.
Daptomycin: Effective against resistant gram-positive infections.
Metronidazole: Used for anaerobic infections and C. difficile colitis.
Clindamycin: Broadly effective for gram-positive and anaerobic coverage, often associated with C. difficile risk.
Importance of completing prescribed courses of antibiotics.
Advising against self-discontinuation of antibiotics without medical guidance.
Education on potential side effects and proper administration practices.